zidovudine has been researched along with Heart Septal Defects, Ventricular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanche, S; Bonnet, D; Delmas, S; Dollfus, C; Faye, A; Khoshnood, B; Le Chenadec, J; Lelong, N; Mandelbrot, L; Sibiude, J; Tubiana, R; Warszawski, J | 1 |
Albano, JD; Koram, N; Napier, MD; Scheuerle, AE; Tilson, H; Vannappagari, V | 1 |
1 trial(s) available for zidovudine and Heart Septal Defects, Ventricular
Article | Year |
---|---|
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Topics: Adult; Anti-HIV Agents; Drug Combinations; Echocardiography; Female; Follow-Up Studies; France; Heart Defects, Congenital; Heart Septal Defects, Ventricular; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Sex Factors; Uterus; Young Adult; Zidovudine | 2015 |
1 other study(ies) available for zidovudine and Heart Septal Defects, Ventricular
Article | Year |
---|---|
Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Argentina; Brazil; Case-Control Studies; Female; France; Gestational Age; Heart Defects, Congenital; Heart Septal Defects, Ventricular; HIV Infections; Humans; Live Birth; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Prenatal Exposure Delayed Effects; Prevalence; Prospective Studies; Registries; Risk Factors; South Africa; Uganda; United Kingdom; United States; Young Adult; Zidovudine | 2016 |